← Back to Knowledge Base

Primary topic: ZMIZ1 celiac gene

ZMIZ1 Gene and Metabolism: What It Can Mean in a Pathway Report

ZMIZ1 is tracked as a small-effect non-HLA celiac susceptibility locus.

What is the ZMIZ1 gene?

ZMIZ1 is a regulatory gene linked to immune susceptibility signals in celiac GWAS evidence. It is not a gluten digestion gene.

How ZMIZ1 affects metabolism

A ZMIZ1 signal can add modest immune-risk context but should not be used as a standalone explanation for symptoms.

What happens when ZMIZ1 is altered

A ZMIZ1 signal needs HLA, serology, symptoms, and clinician context before it matters in practice.

Curated SNP evidence for ZMIZ1

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

ZMIZ1 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.

Open the sample report
rs1250552ZMIZ1 celiac susceptibility signal1 claims · 3 study rows

disease trait · AA

Non-HLA ZMIZ1 celiac susceptibility context

Moderate

rs1250552 AA carries the GWAS Catalog celiac disease risk A allele at the ZMIZ1 immune locus.

ZMIZ1 rs1250552 AA is scored as small non-HLA celiac susceptibility context.

Likely effectHigher trait association
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • digestive symptoms where celiac testing is relevant
  • family context around autoimmune disease
  • genetic immune-risk findings that need prioritization

Biomarkers to validate

tTG-IgA with total IgA

Primary serology context.

EMA or DGP context

Adds follow-up context when clinically appropriate.

Formal HLA-DQ typing

Clarifies whether the main celiac-compatible HLA background is present.

Where DNA analysis helps

DNA helps place ZMIZ1 inside a broader celiac immune-risk pattern rather than treating it as a yes/no answer.

Example interpretation

ZMIZ1 may add useful context when its SNP evidence lines up with the broader pathway signal.

Suggested validation: celiac serology and HLA-DQ context.

What to do next

  • Keep ZMIZ1 secondary to HLA-DQ and serology.
  • Avoid gluten restriction decisions from this gene alone.
  • Use clinical testing if celiac disease is a real concern.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages